ARTH   $6.4  -16.67% Market Closed

Arch Therapeutics Inc
Last Events:

2023-03-29 Trend pattern changed from расходящийся треугольник to расширяющаяся формация.

2023-03-29 Signal in Stochastic changed from bearish weakening to bullish weakening. The stochastic indicator is in the upper part of the neutral territory and it heading south. These factors indicate that the downside trend is forming. Last signal: main and signal line crossing.

2023-03-29 Signal in MACD changed from bearish weakening to bearish recovery. Oscillator MACD is in the negative territory it's lower than the signal line and falls. These factors mean that negative mood prevails. Last signal: signal line crossed the middle level.

2023-03-29 Signal in RSI changed from bearish weakening to bearish recovery. RSI indicator is in the lower part of the neutral territory and it falls. These factors indicate that negative dynamics persists. Last signal: exit from the overbought zone.

2023-03-29 Trend pattern changed from расширяющаяся формация to расходящийся треугольник.

2023-03-29 Signal in Stochastic changed from bullish weakening to bearish weakening. The stochastic indicator is in the lower part of the neutral territory and it grows. These factors indicate that the upside trend is confirmed. Last signal: main and signal line crossing.

2023-03-29 Signal in MACD changed from bearish recovery to bearish weakening. Oscillator MACD is in the negative territory it's lower than the signal line and grows. These factors mean that the falling trend persists, but the growth rate is declining. Last signal: signal line crossed the middle level.

2023-03-29 Signal in RSI changed from bearish recovery to bearish weakening. RSI indicator is in the lower part of the neutral territory and it grows. These factors indicate that the upside trend is confirmed. Last signal: exit from the overbought zone.


Current temperature: 5.56
ST: 0, Cor:

50-50 Year Forecast
Low with 50% probability: 3.83
Target: 600.00
High with 50% probability: 23.03
Analyst Recommendations:
Number of estimates 1
Target Price Mean 600.00
Mean unverified/preliminary 600.00 / 600.00
Target Price Low / High 600.00 / 600.00
Median / STD DEV 600.00 / 0.00
Tech Forecasts:
More signals
  < 1M 1-3M > 3M
total Sell Sell Sell
rsi ActivelyBuy Sell Sell
macd Sell Sell Sell
stoch Sell Sell -
ma20 - - -
ma50 - - -
ma100 - - -
Candlestick PatternOct. 7, 2022 Dragon Fly - is formed when the opening and the closing prices are at the highest of the day. If it has a longer lower shadow it signals a more bullish trend. When appearing at market bottoms it is considered to be a reversal signal.
ISIN US03939W1099
ceo Dr. Terrence W. Norchi M.D.
Website https://www.archtherapeutics.com
Arch Therapeutics, Inc., together with its subsidiaries, operates as a biotechnology company in the United States. It develops and markets products based on its AC5 self-assembling technology platform to stop bleeding and control leaking, as well as manages wounds during surgery, trauma, and interventional care or from disease. The company's flagship products include AC5 advanced wound system and AC5 topical hemostat, which are intended for skin applications, such as management of complicated chronic wounds or acute surgical wounds. It is also involved in the development of AC5-G for gastrointestinal endoscopic procedures, and AC5-V and AC5 surgical hemostat for hemostasis inside the body. The company was founded in 2006 and is based in Framingham, Massachusetts.